Innovation for Global Health
Indexus products are currently not available for diagnostic use
Indexus Biomedical is pioneering the development of innovative hybrid (multifunctional) technologies and products designed to enable small decentralized laboratories to deliver expanded menu of advanced in-vitro diagnostic (IVD) tests closer to the patient's home, offering faster and accurate results at reduced costs.
Small decentralized laboratories include laboratories associated with urgent care and primary care clinics, physicians' offices, small hospitals, rural clinics, certain mobile clinics, and all other small to medium sized independent laboratories.
Innovations for Global Health!
Indexus has developed an IP portfolio of uniquely advantageous molecular dx, immuno assay, cellular analysis, and hematology analysis technologies that will work together on a single multifunction instrument. The portfolio includes instrumentation, reagents, and assay protocols.
Bringing Advanced Testing to the Decentralized Primary Care Laboratory
Our flagship product, the Indexus-TriSense Dx multifunction blood analysis system is a first of a kind instrument delivering molecular and immuno-diagnostic tests on a small, easy to use, and affordable POC platform that also performs routine hematology tests.
Molecular Dx Tests for Infectious Diseases
including HIV 1, 2 and O, Hepatitis A, B, C and E, Respiratory Virus (Flu A/B, COVID-19)
Vector Borne Diseases, including Malaria and Dengue
CBC with extended 5-Part Differential
Immune System Monitoring Assay (CD4/CD8 count Count)
Future Tests (Menu Expansion)
Hematological Malignancies (leukemia, lymphoma)
Cancer Biomarker Assays
Multiplexed Inflammatory Biomarker Assay
Our global-health focused products will deliver significantly increased access to affordable high-quality diagnostic testing for patients in both the developing and the developed world.
System Integration: Integrating and automating multiple third-party point of care devices into unified laboratory workflow systems.
Procurement: Providing support to healthcare providers and government agencies in product sourcing, evaluations, and procurement for emerging healthcare needs.
Market Research: Providing market research in in-vitro diagnostics industry.
Indexus Biomedical has received support from the following organizations for its technology and product development initiatives:
NC Small Business and
Technology Development Center
“The TriSense Dx system will revolutionize the way our diagnostic labs approach patient samples!”
Dr. Naba Hazarika, MD
Head of Microbiology Department
Gauhati Medical College Hospital
In-charge, NACO-HIV2 Reference Lab and WHO Measles Surveillance Lab India
“Multifunction blood testing system will offer an extremely innovative solution to the small to the medium sized hospitals, clinics and diagnostic laboratories”
Thomas N. Denny, MPhil
Professor of Medicine
Chief Operatig Officer, Duke CHAVI-ID (Center for HIV/AIDS Vaccine Immunology)
Duke University Medical School
Durham, NC USA
“Indexus TriSense Dx will be a perfect addition to the instruments currently used in the fight against leukemia and other diseases, for which early detection vastly improves the chances of cure.”
Dr. Philippa Sprinz, MD
Hasbro Children's Hospital, Rhode Island
Ex-Director of Pediatric Hematology and Oncology
Boston Medical Center,
Boston, MA USA
Indexus Biomedical LLC
2 Davis Drive
Durham, NC 27709
“For a great number of hospitals, clinics and laboratories in tier 2 and tier 3 cities in India this instrument
will fill a critical void in the diagnostic testing continuum”
Dr. Indrajit Kalita, MD, Director of Diagnostics Pathology Labs, International Hospital